US Equity
MGNX
— MACROGENICS, INC.MacroGenics, Inc. is a clinical-stage biopharmaceutical company developing antibody-based therapeutics for the treatment of cancer.
💰 Market cap: $254.25M📍 9704 Medical Center Drive, ROCKVILLE, MD, 20850 US🏷️ Biotechnology & Medical Research💵 Previous close: $3.70🔢 3,652 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $3.70 |
| 2026-07-23 | $4.01 |
| 2026-07-22 | $4.30 |
| 2026-07-21 | $4.54 |
| 2026-07-20 | $4.32 |
| 2026-07-17 | $4.49 |
| 2026-07-16 | $4.12 |
| 2026-07-15 | $4.32 |
| 2026-07-14 | $4.29 |
| 2026-07-13 | $4.50 |
| 2026-07-10 | $4.33 |
| 2026-07-09 | $4.57 |
| 2026-07-08 | $4.66 |
| 2026-07-07 | $4.75 |
| 2026-07-06 | $4.57 |
| 2026-07-02 | $4.71 |
| 2026-07-01 | $4.62 |
| 2026-06-30 | $4.62 |
| 2026-06-29 | $4.86 |
| 2026-06-26 | $4.81 |
| 2026-06-25 | $4.66 |
| 2026-06-24 | $4.78 |
| 2026-06-23 | $4.69 |
| 2026-06-22 | $4.58 |
| 2026-06-18 | $4.13 |
| 2026-06-17 | $3.96 |
| 2026-06-16 | $3.88 |
| 2026-06-15 | $4.13 |
| 2026-06-12 | $3.96 |
| 2026-06-11 | $4.01 |
| 2026-06-10 | $3.87 |
| 2026-06-09 | $3.91 |
| 2026-06-08 | $3.88 |
| 2026-06-05 | $3.91 |
| 2026-06-04 | $4.25 |
| 2026-06-03 | $4.20 |
| 2026-06-02 | $4.05 |
| 2026-06-01 | $4.14 |
| 2026-05-29 | $4.16 |
| 2026-05-28 | $4.21 |
| 2026-05-27 | $4.38 |
| 2026-05-26 | $4.47 |
| 2026-05-22 | $4.53 |
| 2026-05-21 | $4.24 |
| 2026-05-20 | $4.46 |
| 2026-05-19 | $4.52 |
| 2026-05-18 | $4.35 |
| 2026-05-15 | $4.25 |
| 2026-05-14 | $4.16 |
| 2026-05-13 | $3.45 |
| 2026-05-12 | $3.52 |
| 2026-05-11 | $2.95 |
| 2026-05-08 | $3.00 |
| 2026-05-07 | $2.94 |
| 2026-05-06 | $3.01 |
| 2026-05-05 | $3.15 |
| 2026-05-04 | $3.20 |
| 2026-05-01 | $3.13 |
| 2026-04-30 | $3.08 |
| 2026-04-29 | $2.94 |
| 2026-04-28 | $3.01 |